Home › Funds › Madison Avenue Partners, LP › SOLV

Madison Avenue Partners, LP position in SOLV

SOLVENTUM CORP · Health Care

Madison Avenue Partners, LP reported holding 476,282 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$42.0M, representing 1.67% of its reported portfolio and ranking #19 among its reported holdings. Madison Avenue Partners, LP has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)476.28K sh
Reported value held$41.98M
Portfolio Weight1.67%
First reportedQ2 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Madison Avenue Partners, LP's SOLV position evolved

Madison Avenue Partners, LP first disclosed a stake in SOLV in Q2 2024 at 2,464,934 shares (US$130.3M). The position peaked in Q1 2025 at 2,813,017 shares, worth US$213.9M. Across 10 filings, Madison Avenue Partners, LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 476,282 shares valued at US$42.0M — a reduction of -1,264,939 shares quarter over quarter.. Notable position changes include a 73% trim in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 2.46M $130.35M New
Q3 2024 2.83M $197.15M Add
Q4 2024 2.83M $186.80M Hold
Q1 2025 2.81M $213.90M Reduce
Q2 2025 2.24M $170.21M Reduce
Q3 2025 1.99M $145.15M Reduce
Q4 2025 1.99M $157.53M Hold
Q1 2026 1.88M $122.49M Reduce
Q2 2026 1.74M $134.34M Reduce
Q3 2026 476.28K $41.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 39 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has Madison Avenue Partners, LP held SOLV?

Madison Avenue Partners, LP has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Madison Avenue Partners, LP's current position in SOLV?

As of Q3 2026, Madison Avenue Partners, LP holds 476.28K shares of SOLV (SOLVENTUM CORP), valued at $41.98M, representing 1.67% of its reported portfolio and ranking #19.

Has Madison Avenue Partners, LP been buying or selling SOLV?

In the latest 13F filing (Q3 2026), Madison Avenue Partners, LP reduced its position in SOLV. The position peaked in Q1 2025 at 2.81M shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.